nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—CYP3A7—Ifosfamide—testicular cancer	0.12	0.204	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.12	0.204	CbGbCtD
Iloperidone—CYP3A5—Ifosfamide—testicular cancer	0.0903	0.153	CbGbCtD
Iloperidone—CYP2E1—Etoposide—testicular cancer	0.0555	0.0939	CbGbCtD
Iloperidone—CYP3A5—Etoposide—testicular cancer	0.0431	0.073	CbGbCtD
Iloperidone—CYP3A4—Ifosfamide—testicular cancer	0.0352	0.0595	CbGbCtD
Iloperidone—CYP1A2—Etoposide—testicular cancer	0.0321	0.0543	CbGbCtD
Iloperidone—HTR7—vas deferens—testicular cancer	0.0312	0.348	CbGeAlD
Iloperidone—CYP2D6—Vinblastine—testicular cancer	0.0294	0.0497	CbGbCtD
Iloperidone—CYP3A4—Vinblastine—testicular cancer	0.0187	0.0316	CbGbCtD
Iloperidone—CYP2D6—Doxorubicin—testicular cancer	0.018	0.0305	CbGbCtD
Iloperidone—CYP3A4—Etoposide—testicular cancer	0.0168	0.0285	CbGbCtD
Iloperidone—Gefitinib—STK10—testicular cancer	0.0168	1	CrCbGaD
Iloperidone—HTR7—vein—testicular cancer	0.0133	0.148	CbGeAlD
Iloperidone—CYP3A4—Doxorubicin—testicular cancer	0.0115	0.0194	CbGbCtD
Iloperidone—HTR2A—vein—testicular cancer	0.00827	0.0922	CbGeAlD
Iloperidone—DRD4—testis—testicular cancer	0.0039	0.0435	CbGeAlD
Iloperidone—SIGMAR1—seminal vesicle—testicular cancer	0.00276	0.0308	CbGeAlD
Iloperidone—ADRA2C—seminal vesicle—testicular cancer	0.00217	0.0242	CbGeAlD
Iloperidone—ADRA2A—seminal vesicle—testicular cancer	0.00173	0.0193	CbGeAlD
Iloperidone—HTR7—gonad—testicular cancer	0.0017	0.019	CbGeAlD
Iloperidone—CYP2E1—seminal vesicle—testicular cancer	0.00169	0.0189	CbGeAlD
Iloperidone—SIGMAR1—female gonad—testicular cancer	0.00162	0.0181	CbGeAlD
Iloperidone—HTR2A—embryo—testicular cancer	0.00157	0.0175	CbGeAlD
Iloperidone—SIGMAR1—testis—testicular cancer	0.00144	0.016	CbGeAlD
Iloperidone—ADRA2C—female gonad—testicular cancer	0.00127	0.0142	CbGeAlD
Iloperidone—ADRA2A—gonad—testicular cancer	0.00125	0.0139	CbGeAlD
Iloperidone—HTR7—testis—testicular cancer	0.00123	0.0137	CbGeAlD
Iloperidone—DRD2—testis—testicular cancer	0.00116	0.0129	CbGeAlD
Iloperidone—ADRA2C—testis—testicular cancer	0.00113	0.0126	CbGeAlD
Iloperidone—CYP3A5—female gonad—testicular cancer	0.00107	0.0119	CbGeAlD
Iloperidone—HTR2A—gonad—testicular cancer	0.00106	0.0118	CbGeAlD
Iloperidone—SIGMAR1—lymph node—testicular cancer	0.00104	0.0116	CbGeAlD
Iloperidone—HRH1—female gonad—testicular cancer	0.00103	0.0115	CbGeAlD
Iloperidone—ADRA2A—female gonad—testicular cancer	0.00102	0.0113	CbGeAlD
Iloperidone—HRH1—testis—testicular cancer	0.000917	0.0102	CbGeAlD
Iloperidone—ADRA2A—testis—testicular cancer	0.000901	0.01	CbGeAlD
Iloperidone—CYP2E1—testis—testicular cancer	0.000881	0.00983	CbGeAlD
Iloperidone—ADRA2C—lymph node—testicular cancer	0.000818	0.00912	CbGeAlD
Iloperidone—CYP2D6—female gonad—testicular cancer	0.000787	0.00877	CbGeAlD
Iloperidone—HTR2A—testis—testicular cancer	0.000766	0.00854	CbGeAlD
Iloperidone—CYP2D6—testis—testicular cancer	0.000698	0.00778	CbGeAlD
Iloperidone—HRH1—lymph node—testicular cancer	0.000665	0.00741	CbGeAlD
Iloperidone—ADRA2A—lymph node—testicular cancer	0.000653	0.00728	CbGeAlD
Iloperidone—Oedema—Ifosfamide—testicular cancer	0.000642	0.00212	CcSEcCtD
Iloperidone—Vision blurred—Cisplatin—testicular cancer	0.000639	0.00211	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000638	0.00211	CcSEcCtD
Iloperidone—Asthenia—Vinblastine—testicular cancer	0.000638	0.00211	CcSEcCtD
Iloperidone—Infection—Ifosfamide—testicular cancer	0.000638	0.00211	CcSEcCtD
Iloperidone—Tremor—Cisplatin—testicular cancer	0.000635	0.0021	CcSEcCtD
Iloperidone—Lethargy—Methotrexate—testicular cancer	0.00063	0.00209	CcSEcCtD
Iloperidone—Nervous system disorder—Ifosfamide—testicular cancer	0.000629	0.00208	CcSEcCtD
Iloperidone—Anaemia—Cisplatin—testicular cancer	0.000627	0.00207	CcSEcCtD
Iloperidone—Renal failure acute—Epirubicin—testicular cancer	0.000626	0.00207	CcSEcCtD
Iloperidone—Feeling abnormal—Bleomycin—testicular cancer	0.000619	0.00205	CcSEcCtD
Iloperidone—Increased appetite—Epirubicin—testicular cancer	0.000615	0.00204	CcSEcCtD
Iloperidone—Diarrhoea—Vinblastine—testicular cancer	0.000608	0.00201	CcSEcCtD
Iloperidone—Leukopenia—Cisplatin—testicular cancer	0.000607	0.00201	CcSEcCtD
Iloperidone—Fatigue—Dactinomycin—testicular cancer	0.000604	0.002	CcSEcCtD
Iloperidone—Hypotension—Ifosfamide—testicular cancer	0.0006	0.00198	CcSEcCtD
Iloperidone—Muscle spasms—Etoposide—testicular cancer	0.000597	0.00198	CcSEcCtD
Iloperidone—Body temperature increased—Bleomycin—testicular cancer	0.000594	0.00196	CcSEcCtD
Iloperidone—Cardiac failure—Epirubicin—testicular cancer	0.000592	0.00196	CcSEcCtD
Iloperidone—Lethargy—Epirubicin—testicular cancer	0.00059	0.00195	CcSEcCtD
Iloperidone—Dizziness—Vinblastine—testicular cancer	0.000588	0.00194	CcSEcCtD
Iloperidone—Mood swings—Methotrexate—testicular cancer	0.000585	0.00194	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000585	0.00193	CcSEcCtD
Iloperidone—Renal failure acute—Doxorubicin—testicular cancer	0.000579	0.00192	CcSEcCtD
Iloperidone—Myalgia—Cisplatin—testicular cancer	0.000577	0.00191	CcSEcCtD
Iloperidone—Feeling abnormal—Dactinomycin—testicular cancer	0.000577	0.00191	CcSEcCtD
Iloperidone—Nausea—Chlorambucil—testicular cancer	0.000576	0.00191	CcSEcCtD
Iloperidone—Paraesthesia—Ifosfamide—testicular cancer	0.000576	0.00191	CcSEcCtD
Iloperidone—Anaemia—Etoposide—testicular cancer	0.000574	0.0019	CcSEcCtD
Iloperidone—Dyspnoea—Ifosfamide—testicular cancer	0.000572	0.00189	CcSEcCtD
Iloperidone—Somnolence—Ifosfamide—testicular cancer	0.000571	0.00189	CcSEcCtD
Iloperidone—Increased appetite—Doxorubicin—testicular cancer	0.000569	0.00188	CcSEcCtD
Iloperidone—Affect lability—Epirubicin—testicular cancer	0.000569	0.00188	CcSEcCtD
Iloperidone—Breast disorder—Methotrexate—testicular cancer	0.000558	0.00185	CcSEcCtD
Iloperidone—Vertigo—Etoposide—testicular cancer	0.000558	0.00185	CcSEcCtD
Iloperidone—Leukopenia—Etoposide—testicular cancer	0.000556	0.00184	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000554	0.00183	CcSEcCtD
Iloperidone—Body temperature increased—Dactinomycin—testicular cancer	0.000554	0.00183	CcSEcCtD
Iloperidone—Fatigue—Ifosfamide—testicular cancer	0.000553	0.00183	CcSEcCtD
Iloperidone—Oedema—Cisplatin—testicular cancer	0.000553	0.00183	CcSEcCtD
Iloperidone—Infection—Cisplatin—testicular cancer	0.00055	0.00182	CcSEcCtD
Iloperidone—Cardiac failure—Doxorubicin—testicular cancer	0.000548	0.00181	CcSEcCtD
Iloperidone—Mood swings—Epirubicin—testicular cancer	0.000548	0.00181	CcSEcCtD
Iloperidone—Lethargy—Doxorubicin—testicular cancer	0.000546	0.00181	CcSEcCtD
Iloperidone—Nervous system disorder—Cisplatin—testicular cancer	0.000543	0.00179	CcSEcCtD
Iloperidone—Tachycardia—Cisplatin—testicular cancer	0.00054	0.00179	CcSEcCtD
Iloperidone—Asthenia—Bleomycin—testicular cancer	0.000539	0.00178	CcSEcCtD
Iloperidone—Dehydration—Epirubicin—testicular cancer	0.000538	0.00178	CcSEcCtD
Iloperidone—Asthma—Methotrexate—testicular cancer	0.000534	0.00177	CcSEcCtD
Iloperidone—Feeling abnormal—Ifosfamide—testicular cancer	0.000529	0.00175	CcSEcCtD
Iloperidone—Nausea—Vinblastine—testicular cancer	0.000528	0.00175	CcSEcCtD
Iloperidone—Orthostatic hypotension—Epirubicin—testicular cancer	0.000528	0.00175	CcSEcCtD
Iloperidone—Affect lability—Doxorubicin—testicular cancer	0.000527	0.00174	CcSEcCtD
Iloperidone—Hypokalaemia—Epirubicin—testicular cancer	0.000526	0.00174	CcSEcCtD
Iloperidone—Breast disorder—Epirubicin—testicular cancer	0.000522	0.00173	CcSEcCtD
Iloperidone—Hypotension—Cisplatin—testicular cancer	0.000517	0.00171	CcSEcCtD
Iloperidone—Nasopharyngitis—Epirubicin—testicular cancer	0.000517	0.00171	CcSEcCtD
Iloperidone—Abdominal discomfort—Methotrexate—testicular cancer	0.000512	0.00169	CcSEcCtD
Iloperidone—Gastritis—Epirubicin—testicular cancer	0.000512	0.00169	CcSEcCtD
Iloperidone—Confusional state—Etoposide—testicular cancer	0.000511	0.00169	CcSEcCtD
Iloperidone—Body temperature increased—Ifosfamide—testicular cancer	0.000507	0.00168	CcSEcCtD
Iloperidone—Mood swings—Doxorubicin—testicular cancer	0.000507	0.00168	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000504	0.00167	CcSEcCtD
Iloperidone—Infection—Etoposide—testicular cancer	0.000504	0.00167	CcSEcCtD
Iloperidone—Asthenia—Dactinomycin—testicular cancer	0.000503	0.00166	CcSEcCtD
Iloperidone—Asthma—Epirubicin—testicular cancer	0.0005	0.00165	CcSEcCtD
Iloperidone—Dysuria—Methotrexate—testicular cancer	0.000499	0.00165	CcSEcCtD
Iloperidone—Dehydration—Doxorubicin—testicular cancer	0.000497	0.00165	CcSEcCtD
Iloperidone—Paraesthesia—Cisplatin—testicular cancer	0.000497	0.00164	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000496	0.00164	CcSEcCtD
Iloperidone—Tachycardia—Etoposide—testicular cancer	0.000495	0.00164	CcSEcCtD
Iloperidone—Dyspnoea—Cisplatin—testicular cancer	0.000493	0.00163	CcSEcCtD
Iloperidone—Erectile dysfunction—Methotrexate—testicular cancer	0.000492	0.00163	CcSEcCtD
Iloperidone—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000489	0.00162	CcSEcCtD
Iloperidone—Hypokalaemia—Doxorubicin—testicular cancer	0.000487	0.00161	CcSEcCtD
Iloperidone—Breast disorder—Doxorubicin—testicular cancer	0.000483	0.0016	CcSEcCtD
Iloperidone—Diarrhoea—Dactinomycin—testicular cancer	0.000479	0.00159	CcSEcCtD
Iloperidone—Nasopharyngitis—Doxorubicin—testicular cancer	0.000478	0.00158	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000478	0.00158	CcSEcCtD
Iloperidone—Hypotension—Etoposide—testicular cancer	0.000474	0.00157	CcSEcCtD
Iloperidone—Rash—Bleomycin—testicular cancer	0.000474	0.00157	CcSEcCtD
Iloperidone—Gastritis—Doxorubicin—testicular cancer	0.000473	0.00157	CcSEcCtD
Iloperidone—Dermatitis—Bleomycin—testicular cancer	0.000473	0.00156	CcSEcCtD
Iloperidone—Dysuria—Epirubicin—testicular cancer	0.000467	0.00155	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000464	0.00154	CcSEcCtD
Iloperidone—Stomatitis—Methotrexate—testicular cancer	0.000464	0.00153	CcSEcCtD
Iloperidone—Conjunctivitis—Methotrexate—testicular cancer	0.000463	0.00153	CcSEcCtD
Iloperidone—Asthma—Doxorubicin—testicular cancer	0.000462	0.00153	CcSEcCtD
Iloperidone—Pollakiuria—Epirubicin—testicular cancer	0.000462	0.00153	CcSEcCtD
Iloperidone—Asthenia—Ifosfamide—testicular cancer	0.00046	0.00152	CcSEcCtD
Iloperidone—Feeling abnormal—Cisplatin—testicular cancer	0.000456	0.00151	CcSEcCtD
Iloperidone—Paraesthesia—Etoposide—testicular cancer	0.000455	0.00151	CcSEcCtD
Iloperidone—Weight increased—Epirubicin—testicular cancer	0.000455	0.0015	CcSEcCtD
Iloperidone—Weight decreased—Epirubicin—testicular cancer	0.000452	0.0015	CcSEcCtD
Iloperidone—Dyspnoea—Etoposide—testicular cancer	0.000452	0.00149	CcSEcCtD
Iloperidone—Somnolence—Etoposide—testicular cancer	0.000451	0.00149	CcSEcCtD
Iloperidone—Hepatobiliary disease—Methotrexate—testicular cancer	0.00045	0.00149	CcSEcCtD
Iloperidone—Epistaxis—Methotrexate—testicular cancer	0.000449	0.00149	CcSEcCtD
Iloperidone—Nausea—Bleomycin—testicular cancer	0.000446	0.00148	CcSEcCtD
Iloperidone—Rash—Dactinomycin—testicular cancer	0.000442	0.00146	CcSEcCtD
Iloperidone—Diarrhoea—Ifosfamide—testicular cancer	0.000439	0.00145	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Etoposide—testicular cancer	0.000438	0.00145	CcSEcCtD
Iloperidone—Body temperature increased—Cisplatin—testicular cancer	0.000437	0.00145	CcSEcCtD
Iloperidone—Fatigue—Etoposide—testicular cancer	0.000437	0.00145	CcSEcCtD
Iloperidone—Stomatitis—Epirubicin—testicular cancer	0.000434	0.00144	CcSEcCtD
Iloperidone—Conjunctivitis—Epirubicin—testicular cancer	0.000433	0.00143	CcSEcCtD
Iloperidone—Dysuria—Doxorubicin—testicular cancer	0.000432	0.00143	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00043	0.00142	CcSEcCtD
Iloperidone—Pollakiuria—Doxorubicin—testicular cancer	0.000427	0.00141	CcSEcCtD
Iloperidone—Dizziness—Ifosfamide—testicular cancer	0.000424	0.0014	CcSEcCtD
Iloperidone—Urinary tract disorder—Methotrexate—testicular cancer	0.000422	0.0014	CcSEcCtD
Iloperidone—Hepatobiliary disease—Epirubicin—testicular cancer	0.000421	0.00139	CcSEcCtD
Iloperidone—Weight increased—Doxorubicin—testicular cancer	0.000421	0.00139	CcSEcCtD
Iloperidone—Epistaxis—Epirubicin—testicular cancer	0.00042	0.00139	CcSEcCtD
Iloperidone—Urethral disorder—Methotrexate—testicular cancer	0.000419	0.00139	CcSEcCtD
Iloperidone—Weight decreased—Doxorubicin—testicular cancer	0.000418	0.00138	CcSEcCtD
Iloperidone—Feeling abnormal—Etoposide—testicular cancer	0.000418	0.00138	CcSEcCtD
Iloperidone—Nausea—Dactinomycin—testicular cancer	0.000416	0.00138	CcSEcCtD
Iloperidone—Rash—Ifosfamide—testicular cancer	0.000405	0.00134	CcSEcCtD
Iloperidone—Dermatitis—Ifosfamide—testicular cancer	0.000404	0.00134	CcSEcCtD
Iloperidone—Stomatitis—Doxorubicin—testicular cancer	0.000402	0.00133	CcSEcCtD
Iloperidone—Body temperature increased—Etoposide—testicular cancer	0.000401	0.00133	CcSEcCtD
Iloperidone—Conjunctivitis—Doxorubicin—testicular cancer	0.000401	0.00133	CcSEcCtD
Iloperidone—Eye disorder—Methotrexate—testicular cancer	0.000399	0.00132	CcSEcCtD
Iloperidone—Tinnitus—Methotrexate—testicular cancer	0.000398	0.00132	CcSEcCtD
Iloperidone—Asthenia—Cisplatin—testicular cancer	0.000397	0.00131	CcSEcCtD
Iloperidone—Cardiac disorder—Methotrexate—testicular cancer	0.000397	0.00131	CcSEcCtD
Iloperidone—Urinary tract disorder—Epirubicin—testicular cancer	0.000395	0.00131	CcSEcCtD
Iloperidone—Connective tissue disorder—Epirubicin—testicular cancer	0.000393	0.0013	CcSEcCtD
Iloperidone—Urethral disorder—Epirubicin—testicular cancer	0.000392	0.0013	CcSEcCtD
Iloperidone—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00039	0.00129	CcSEcCtD
Iloperidone—Epistaxis—Doxorubicin—testicular cancer	0.000389	0.00129	CcSEcCtD
Iloperidone—Angiopathy—Methotrexate—testicular cancer	0.000388	0.00128	CcSEcCtD
Iloperidone—Mediastinal disorder—Methotrexate—testicular cancer	0.000385	0.00127	CcSEcCtD
Iloperidone—Nausea—Ifosfamide—testicular cancer	0.000381	0.00126	CcSEcCtD
Iloperidone—Diarrhoea—Cisplatin—testicular cancer	0.000379	0.00125	CcSEcCtD
Iloperidone—Mental disorder—Methotrexate—testicular cancer	0.000374	0.00124	CcSEcCtD
Iloperidone—Eye disorder—Epirubicin—testicular cancer	0.000374	0.00124	CcSEcCtD
Iloperidone—Tinnitus—Epirubicin—testicular cancer	0.000373	0.00123	CcSEcCtD
Iloperidone—Malnutrition—Methotrexate—testicular cancer	0.000372	0.00123	CcSEcCtD
Iloperidone—Cardiac disorder—Epirubicin—testicular cancer	0.000371	0.00123	CcSEcCtD
Iloperidone—Urinary tract disorder—Doxorubicin—testicular cancer	0.000365	0.00121	CcSEcCtD
Iloperidone—Asthenia—Etoposide—testicular cancer	0.000364	0.0012	CcSEcCtD
Iloperidone—Connective tissue disorder—Doxorubicin—testicular cancer	0.000364	0.0012	CcSEcCtD
Iloperidone—Angiopathy—Epirubicin—testicular cancer	0.000363	0.0012	CcSEcCtD
Iloperidone—Urethral disorder—Doxorubicin—testicular cancer	0.000363	0.0012	CcSEcCtD
Iloperidone—Mediastinal disorder—Epirubicin—testicular cancer	0.00036	0.00119	CcSEcCtD
Iloperidone—Arrhythmia—Epirubicin—testicular cancer	0.000357	0.00118	CcSEcCtD
Iloperidone—Vision blurred—Methotrexate—testicular cancer	0.000351	0.00116	CcSEcCtD
Iloperidone—Mental disorder—Epirubicin—testicular cancer	0.00035	0.00116	CcSEcCtD
Iloperidone—Rash—Cisplatin—testicular cancer	0.000349	0.00115	CcSEcCtD
Iloperidone—Dermatitis—Cisplatin—testicular cancer	0.000349	0.00115	CcSEcCtD
Iloperidone—Malnutrition—Epirubicin—testicular cancer	0.000348	0.00115	CcSEcCtD
Iloperidone—Diarrhoea—Etoposide—testicular cancer	0.000347	0.00115	CcSEcCtD
Iloperidone—Eye disorder—Doxorubicin—testicular cancer	0.000346	0.00114	CcSEcCtD
Iloperidone—Tinnitus—Doxorubicin—testicular cancer	0.000345	0.00114	CcSEcCtD
Iloperidone—Anaemia—Methotrexate—testicular cancer	0.000344	0.00114	CcSEcCtD
Iloperidone—Cardiac disorder—Doxorubicin—testicular cancer	0.000343	0.00114	CcSEcCtD
Iloperidone—Angiopathy—Doxorubicin—testicular cancer	0.000336	0.00111	CcSEcCtD
Iloperidone—Dizziness—Etoposide—testicular cancer	0.000335	0.00111	CcSEcCtD
Iloperidone—Muscle spasms—Epirubicin—testicular cancer	0.000335	0.00111	CcSEcCtD
Iloperidone—Vertigo—Methotrexate—testicular cancer	0.000334	0.00111	CcSEcCtD
Iloperidone—Mediastinal disorder—Doxorubicin—testicular cancer	0.000334	0.0011	CcSEcCtD
Iloperidone—Leukopenia—Methotrexate—testicular cancer	0.000333	0.0011	CcSEcCtD
Iloperidone—Arrhythmia—Doxorubicin—testicular cancer	0.000331	0.00109	CcSEcCtD
Iloperidone—Nausea—Cisplatin—testicular cancer	0.000329	0.00109	CcSEcCtD
Iloperidone—Vision blurred—Epirubicin—testicular cancer	0.000328	0.00109	CcSEcCtD
Iloperidone—Mental disorder—Doxorubicin—testicular cancer	0.000324	0.00107	CcSEcCtD
Iloperidone—Malnutrition—Doxorubicin—testicular cancer	0.000322	0.00107	CcSEcCtD
Iloperidone—Anaemia—Epirubicin—testicular cancer	0.000322	0.00106	CcSEcCtD
Iloperidone—Agitation—Epirubicin—testicular cancer	0.00032	0.00106	CcSEcCtD
Iloperidone—Rash—Etoposide—testicular cancer	0.00032	0.00106	CcSEcCtD
Iloperidone—Dermatitis—Etoposide—testicular cancer	0.000319	0.00106	CcSEcCtD
Iloperidone—Myalgia—Methotrexate—testicular cancer	0.000317	0.00105	CcSEcCtD
Iloperidone—Arthralgia—Methotrexate—testicular cancer	0.000317	0.00105	CcSEcCtD
Iloperidone—Vertigo—Epirubicin—testicular cancer	0.000313	0.00103	CcSEcCtD
Iloperidone—Leukopenia—Epirubicin—testicular cancer	0.000312	0.00103	CcSEcCtD
Iloperidone—Muscle spasms—Doxorubicin—testicular cancer	0.00031	0.00102	CcSEcCtD
Iloperidone—Palpitations—Epirubicin—testicular cancer	0.000308	0.00102	CcSEcCtD
Iloperidone—Confusional state—Methotrexate—testicular cancer	0.000306	0.00101	CcSEcCtD
Iloperidone—Vision blurred—Doxorubicin—testicular cancer	0.000304	0.001	CcSEcCtD
Iloperidone—Infection—Methotrexate—testicular cancer	0.000302	0.000998	CcSEcCtD
Iloperidone—Nausea—Etoposide—testicular cancer	0.000301	0.000996	CcSEcCtD
Iloperidone—Nervous system disorder—Methotrexate—testicular cancer	0.000298	0.000985	CcSEcCtD
Iloperidone—Anaemia—Doxorubicin—testicular cancer	0.000298	0.000985	CcSEcCtD
Iloperidone—Myalgia—Epirubicin—testicular cancer	0.000296	0.00098	CcSEcCtD
Iloperidone—Arthralgia—Epirubicin—testicular cancer	0.000296	0.00098	CcSEcCtD
Iloperidone—Agitation—Doxorubicin—testicular cancer	0.000296	0.000979	CcSEcCtD
Iloperidone—Dry mouth—Epirubicin—testicular cancer	0.00029	0.000959	CcSEcCtD
Iloperidone—Vertigo—Doxorubicin—testicular cancer	0.000289	0.000957	CcSEcCtD
Iloperidone—Leukopenia—Doxorubicin—testicular cancer	0.000288	0.000954	CcSEcCtD
Iloperidone—Confusional state—Epirubicin—testicular cancer	0.000287	0.000948	CcSEcCtD
Iloperidone—Palpitations—Doxorubicin—testicular cancer	0.000285	0.000942	CcSEcCtD
Iloperidone—Oedema—Epirubicin—testicular cancer	0.000284	0.00094	CcSEcCtD
Iloperidone—Hypotension—Methotrexate—testicular cancer	0.000284	0.000938	CcSEcCtD
Iloperidone—Infection—Epirubicin—testicular cancer	0.000282	0.000934	CcSEcCtD
Iloperidone—Nervous system disorder—Epirubicin—testicular cancer	0.000279	0.000922	CcSEcCtD
Iloperidone—Tachycardia—Epirubicin—testicular cancer	0.000277	0.000917	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000277	0.000915	CcSEcCtD
Iloperidone—Arthralgia—Doxorubicin—testicular cancer	0.000274	0.000907	CcSEcCtD
Iloperidone—Myalgia—Doxorubicin—testicular cancer	0.000274	0.000907	CcSEcCtD
Iloperidone—Paraesthesia—Methotrexate—testicular cancer	0.000273	0.000902	CcSEcCtD
Iloperidone—Dyspnoea—Methotrexate—testicular cancer	0.000271	0.000895	CcSEcCtD
Iloperidone—Somnolence—Methotrexate—testicular cancer	0.00027	0.000893	CcSEcCtD
Iloperidone—Dry mouth—Doxorubicin—testicular cancer	0.000268	0.000887	CcSEcCtD
Iloperidone—Hypotension—Epirubicin—testicular cancer	0.000266	0.000878	CcSEcCtD
Iloperidone—Confusional state—Doxorubicin—testicular cancer	0.000265	0.000877	CcSEcCtD
Iloperidone—Oedema—Doxorubicin—testicular cancer	0.000263	0.00087	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000262	0.000867	CcSEcCtD
Iloperidone—Fatigue—Methotrexate—testicular cancer	0.000262	0.000866	CcSEcCtD
Iloperidone—Infection—Doxorubicin—testicular cancer	0.000261	0.000864	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000259	0.000856	CcSEcCtD
Iloperidone—Nervous system disorder—Doxorubicin—testicular cancer	0.000258	0.000853	CcSEcCtD
Iloperidone—Tachycardia—Doxorubicin—testicular cancer	0.000257	0.000849	CcSEcCtD
Iloperidone—Paraesthesia—Epirubicin—testicular cancer	0.000255	0.000844	CcSEcCtD
Iloperidone—Dyspnoea—Epirubicin—testicular cancer	0.000253	0.000838	CcSEcCtD
Iloperidone—Somnolence—Epirubicin—testicular cancer	0.000253	0.000836	CcSEcCtD
Iloperidone—Feeling abnormal—Methotrexate—testicular cancer	0.00025	0.000828	CcSEcCtD
Iloperidone—Hypotension—Doxorubicin—testicular cancer	0.000246	0.000813	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000245	0.000811	CcSEcCtD
Iloperidone—Fatigue—Epirubicin—testicular cancer	0.000245	0.00081	CcSEcCtD
Iloperidone—Body temperature increased—Methotrexate—testicular cancer	0.00024	0.000794	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00024	0.000792	CcSEcCtD
Iloperidone—Paraesthesia—Doxorubicin—testicular cancer	0.000236	0.000781	CcSEcCtD
Iloperidone—Dyspnoea—Doxorubicin—testicular cancer	0.000234	0.000775	CcSEcCtD
Iloperidone—Feeling abnormal—Epirubicin—testicular cancer	0.000234	0.000774	CcSEcCtD
Iloperidone—Somnolence—Doxorubicin—testicular cancer	0.000234	0.000773	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000227	0.000751	CcSEcCtD
Iloperidone—Fatigue—Doxorubicin—testicular cancer	0.000227	0.00075	CcSEcCtD
Iloperidone—Body temperature increased—Epirubicin—testicular cancer	0.000225	0.000743	CcSEcCtD
Iloperidone—Asthenia—Methotrexate—testicular cancer	0.000218	0.000721	CcSEcCtD
Iloperidone—Feeling abnormal—Doxorubicin—testicular cancer	0.000217	0.000717	CcSEcCtD
Iloperidone—Body temperature increased—Doxorubicin—testicular cancer	0.000208	0.000687	CcSEcCtD
Iloperidone—Diarrhoea—Methotrexate—testicular cancer	0.000208	0.000687	CcSEcCtD
Iloperidone—Asthenia—Epirubicin—testicular cancer	0.000204	0.000674	CcSEcCtD
Iloperidone—Dizziness—Methotrexate—testicular cancer	0.000201	0.000664	CcSEcCtD
Iloperidone—Diarrhoea—Epirubicin—testicular cancer	0.000194	0.000643	CcSEcCtD
Iloperidone—Rash—Methotrexate—testicular cancer	0.000191	0.000633	CcSEcCtD
Iloperidone—Dermatitis—Methotrexate—testicular cancer	0.000191	0.000633	CcSEcCtD
Iloperidone—Asthenia—Doxorubicin—testicular cancer	0.000189	0.000624	CcSEcCtD
Iloperidone—Dizziness—Epirubicin—testicular cancer	0.000188	0.000621	CcSEcCtD
Iloperidone—Nausea—Methotrexate—testicular cancer	0.00018	0.000597	CcSEcCtD
Iloperidone—Diarrhoea—Doxorubicin—testicular cancer	0.00018	0.000595	CcSEcCtD
Iloperidone—Rash—Epirubicin—testicular cancer	0.000179	0.000593	CcSEcCtD
Iloperidone—Dermatitis—Epirubicin—testicular cancer	0.000179	0.000592	CcSEcCtD
Iloperidone—Dizziness—Doxorubicin—testicular cancer	0.000174	0.000575	CcSEcCtD
Iloperidone—Nausea—Epirubicin—testicular cancer	0.000169	0.000558	CcSEcCtD
Iloperidone—Rash—Doxorubicin—testicular cancer	0.000166	0.000548	CcSEcCtD
Iloperidone—Dermatitis—Doxorubicin—testicular cancer	0.000166	0.000548	CcSEcCtD
Iloperidone—Nausea—Doxorubicin—testicular cancer	0.000156	0.000517	CcSEcCtD
